| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Chair, Scientific Advisory Brd | Director
2 companies
Wang Xiaodong serves as a Director, Chair, Scientific Advisory Brd at ONC and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 280 sells.
Historically, Wang Xiaodong's trades have earned a middling insider score of 58/100 across 22 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -3.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | ONC Beone Medicines AG | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,028 | $362.97 | $11,262,131.06 | - | - | - | |
| Oct 13, 2026 | BEIGF Beone Medicines AG | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,027 | $350.99 | $10,890,073.93 | - | - | - | |
| Sep 28, 2026 | BEIGF Beone Medicines AG | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,028 | $364.79 | $11,318,557.97 | - | - | - | |
| Sep 8, 2026 | BEIGF Beone Medicines AG | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 38,287 | $349.10 | $13,366,091.76 | - | - | - | |
| Jun 24, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sell10b5-1 | 2,007 | $265.50 | $532,867.36 | -100% | +26.6% | +3.9% | |
| Jun 10, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $262.82 | $10,975,315.61 | - | +31.5% | +0.1% | |
| May 13, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $223.50 | $9,333,272.13 | - | +28.9% | +40.9% | |
| Apr 14, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 48,150 | $242.00 | $11,652,304.59 | - | +3.9% | +27.6% | |
| Mar 18, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $261.28 | $10,911,252.24 | - | +1.2% | +8.0% | |
| Mar 4, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sell10b5-1 | 8,146 | $254.58 | $2,073,826.31 | -100% | -4.4% | +16.2% |